Based on the aggregated intelligence of 130,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, drugstore giant Walgreen (NYSE:WAG) has earned a respected four-star ranking.

With that in mind, let's take a closer look at Walgreen's business, and see what CAPS investors are saying about the stock right now.

Walgreen facts 

Headquarters (founded)

Deerfield, Ill. (1901)

Market Cap

$22 billion


Drug Stores

TTM Revenue

$59.95 billion


CEO Gregory Wasson (since Feb. 2009)

CFO Wade Miquelon (since June 2008)

Return on Equity (average, last three years)


Dividend Yield



CVS Caremark (NYSE:CVS)

Rite Aid (NYSE:RAD)

Wal-Mart (NYSE:WMT)

CAPS members bullish on WAG also bullish on

Johnson & Johnson (NYSE:JNJ)

General Electric (NYSE:GE)

CAPS members bearish on WAG also bearish on

General Motors (NYSE:GM)

Sources: Capital IQ, a division of Standard & Poor's, and Motley Fool CAPS. TTM = trailing 12 months.

Over on CAPS, 94% of the 1,844 members who have rated Walgreen believe the stock will outperform the S&P 500 going forward. These bulls include All-Star DODEA, who is ranked in the top 20% of our community, and fellow Fool Matt Koppenheffer (TMFKopp).

In late January, DODEA noted that Walgreen "has an excellent DRIP program, including the ability to purchase directly from the company. It has a good balance sheet and deals with consumer necessities (medicine, health care) always in high demand."

In a more recent pitch from last month, Matt touches on the supertrend working in the stock's favor:

There's reason to be nervous about competition heating up, but I like the chances that the company swims against the tide in this economy, and then benefits from the boomers for years after that. I've thumbed up CVS too, but I like [Walgreen] a bit more due to historical efficiency/profitability and a somewhat better balance sheet.

What do you think about Walgreen, or any other stock for that matter? Make your voice heard on Motley Fool CAPS today. More than 130,000 investors are waiting to hear what you have to say. CAPS is 100% free, so simply click here to get started.

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Wal-Mart is a Motley Fool Inside Value pick. Johnson & Johnson is a recommendation of Income Investor. The Fool's disclosure policy always gets a perfect score.